Cardinal Health, Inc. (CAH) Position Boosted by GHP Investment Advisors Inc.
GHP Investment Advisors Inc. boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 15.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,224 shares of the company’s stock after buying an additional 2,447 shares during the period. GHP Investment Advisors Inc.’s holdings in Cardinal Health were worth $1,420,000 as of its most recent filing with the SEC.
Other large investors have also recently added to or reduced their stakes in the company. Alpha Windward LLC raised its stake in Cardinal Health by 0.7% in the second quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after buying an additional 17 shares during the last quarter. HL Financial Services LLC raised its stake in Cardinal Health by 0.3% in the first quarter. HL Financial Services LLC now owns 11,887 shares of the company’s stock worth $969,000 after buying an additional 38 shares during the last quarter. Edmond DE Rothschild Holding S.A. raised its stake in Cardinal Health by 0.9% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 4,321 shares of the company’s stock worth $353,000 after buying an additional 39 shares during the last quarter. Wetherby Asset Management Inc. raised its stake in Cardinal Health by 0.5% in the second quarter. Wetherby Asset Management Inc. now owns 8,392 shares of the company’s stock worth $654,000 after buying an additional 44 shares during the last quarter. Finally, Bessemer Group Inc. raised its stake in Cardinal Health by 1.2% in the second quarter. Bessemer Group Inc. now owns 4,238 shares of the company’s stock worth $330,000 after buying an additional 51 shares during the last quarter. 86.41% of the stock is owned by institutional investors and hedge funds.
Cardinal Health, Inc. (NYSE CAH) opened at 66.08 on Friday. The company has a market capitalization of $20.91 billion, a P/E ratio of 16.40 and a beta of 0.80. Cardinal Health, Inc. has a 52-week low of $62.70 and a 52-week high of $84.88. The stock has a 50 day moving average of $72.15 and a 200-day moving average of $76.23.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The company had revenue of $32.97 billion for the quarter, compared to the consensus estimate of $32.73 billion. During the same period last year, the company posted $1.14 EPS. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. On average, equities analysts forecast that Cardinal Health, Inc. will post $4.96 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be paid a $0.4624 dividend. The ex-dividend date is Friday, September 29th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.80%. Cardinal Health’s payout ratio is currently 45.79%.
WARNING: This piece of content was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/26/cardinal-health-inc-cah-position-boosted-by-ghp-investment-advisors-inc.html.
A number of research firms recently weighed in on CAH. Jefferies Group LLC began coverage on shares of Cardinal Health in a report on Wednesday, May 17th. They set a “hold” rating and a $77.00 price target for the company. ValuEngine lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Zacks Investment Research raised shares of Cardinal Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, June 20th. Evercore ISI reissued an “outperform” rating on shares of Cardinal Health in a report on Tuesday, July 4th. Finally, Vetr raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 price objective for the company in a report on Tuesday, June 13th. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $80.46.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.